TITLE:
Nursing Care of Infliximab for Injection in Crohn’s Disease
AUTHORS:
Liu Yang, Xiaomei Cai, Zhimin Tian
KEYWORDS:
Crohn’s Disease, Infliximab, Adverse Reactions, Nursing
JOURNAL NAME:
Yangtze Medicine,
Vol.8 No.2,
May
29,
2024
ABSTRACT: Objective: To summarize the nursing experience of infliximab injection in the treatment of Crohn’s disease. Methods: 25 patients with Crohn’s disease admitted to our hospital from November 2017 to February 2024 were treated with infliximab. The therapeutic effect and adverse drug reactions were observed, nursing intervention was given, and follow-up was performed at 2 weeks, 6 weeks after the first treatment and every 2 months after the treatment cycle. According to Crohn’s disease activity index (CDAI) score, 23 cases with ≤4 were classified as remission stage and 2 cases with 6 were classified as mild activity stage. Infliximab-treated Crohn’s patients had a good prognosis and minor adverse reactions. A correct grasp of the basic knowledge of the drug, standardized operation, attention to the psychological state of the patient, close observation of the change of the patient’s condition, and predictability of the treatment of adverse drug reactions are the guarantee of smooth treatment.